Market Overview:
The global womens health market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of postmenopausal osteoporosis, endometriosis, polycystic ovary syndrome (PCOS), infertility, and menopause. In addition, the increasing demand for minimally invasive procedures is also contributing to the growth of this market. The postmenopausal osteoporosis segment is expected to account for the largest share of the global womens health market in 2018. This segment is growing at a CAGR of 6% from 2018 to 2030 due to rising awareness about bone health among women and increasing incidence rates of postmenopausal osteoporosis across regions.
Product Definition:
The definition of womens health is the health of women, encompassing their physical, mental, and social well-being. The importance of womens health is that it contributes to the overall well-being of society.
Postmenopausal Osteoporosis:
Postmenopausal osteoporosis, also called as Surgical menopause (SM), is the most common type of osteoporosis in women. It usually occurs after 40 years of age and affects around 6.5 million women in the U.S each year according to National Institutes of Health (NIH). The condition is more prevalent among white females but it does not mean that it cannot be cured or treated by any race or gender.
Endometriosis:
Endometriosis is a disease in which the tissue that lines the uterus (womb) grows outside of it, leading to severe pain and infertility. It is estimated that globally more than 5 million women are affected by endometriosis every year. The global rise in female reproductive organ disorders such as Endometriosis has led to an increase in research activities for its treatment and diagnosis.
Application Insights:
The others segment dominated the global womens health market in 2017, accounting for over 45.0% share of the overall revenue. The segment includes reproductive organ disorders, such as uterine cancer and cervical cancer. According to a study published by the WHO in 2018, approximately 1 in 8 women are estimated to develop some form of uterus cancer during their lifetime. Furthermore, according to another study published by National Cancer Center Japan in 2019, around 5280 Japanese women were found to have developed invasive cervical carcinoma during 2014-2017; this represents an increase of about 0.8% compared with 2013-2017 period and a decrease of around 4% when compared with 2012 data (excluding 2012).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of industry players, favorable reimbursement policies, and increasing healthcare expenditure are some factors driving the regional market. According to WHO, North America accounted for approximately 27% share of global women population in 2015 and is expected to grow at an exponential rate over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to rising awareness about women health issues along with government initiatives & programs for improving maternal care & health services delivery systems in developing economies such as India and China.
Growth Factors:
- Increasing awareness about women’s health issues and their prevention
- Rising incidence of lifestyle diseases in women and the consequent need for preventive care
- Growing demand for fertility treatments and other reproductive health services
- Rapid expansion of the healthcare sector in developing countries, where a large population of women is yet to benefit from improved access to healthcare services
- Proliferation of digital health solutions that make it easier for women to access information about their health and connect with service providers
Scope Of The Report
Report Attributes
Report Details
Report Title
Womens Health Market Research Report
By Type
Postmenopausal Osteoporosis, Endometriosis, Polycystic Ovary Syndrome, Infertility, Menopause, Others
By Application
Hospitals, Clinics, Others
By Companies
Allergan, Bayer, Merck, Pfizer, Teva Pharmaceutical, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, Ferring
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Womens Health Market Report Segments:
The global Womens Health market is segmented on the basis of:
Types
Postmenopausal Osteoporosis, Endometriosis, Polycystic Ovary Syndrome, Infertility, Menopause, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Bayer
- Merck
- Pfizer
- Teva Pharmaceutical
- Agile Therapeutics
- Amgen
- Apothecus Pharmaceutical
- AstraZeneca
- Blairex Laboratories
- Bristol-Myers Squibb
- Ferring
Highlights of The Womens Health Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Postmenopausal Osteoporosis
- Endometriosis
- Polycystic Ovary Syndrome
- Infertility
- Menopause
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Womens Health Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Womens health is the health of women. It encompasses everything from reproductive health to mental well-being.
Some of the major players in the womens health market are Allergan, Bayer, Merck, Pfizer, Teva Pharmaceutical, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, Ferring.
The womens health market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Womens Health Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Womens Health Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Womens Health Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Womens Health Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Womens Health Market Size & Forecast, 2020-2028
4.5.1 Womens Health Market Size and Y-o-Y Growth
4.5.2 Womens Health Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Postmenopausal Osteoporosis
5.2.2 Endometriosis
5.2.3 Polycystic Ovary Syndrome
5.2.4 Infertility
5.2.5 Menopause
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Womens Health Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Womens Health Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Postmenopausal Osteoporosis
9.6.2 Endometriosis
9.6.3 Polycystic Ovary Syndrome
9.6.4 Infertility
9.6.5 Menopause
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Postmenopausal Osteoporosis
10.6.2 Endometriosis
10.6.3 Polycystic Ovary Syndrome
10.6.4 Infertility
10.6.5 Menopause
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Postmenopausal Osteoporosis
11.6.2 Endometriosis
11.6.3 Polycystic Ovary Syndrome
11.6.4 Infertility
11.6.5 Menopause
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Postmenopausal Osteoporosis
12.6.2 Endometriosis
12.6.3 Polycystic Ovary Syndrome
12.6.4 Infertility
12.6.5 Menopause
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Postmenopausal Osteoporosis
13.6.2 Endometriosis
13.6.3 Polycystic Ovary Syndrome
13.6.4 Infertility
13.6.5 Menopause
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Womens Health Market: Competitive Dashboard
14.2 Global Womens Health Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Bayer
14.3.3 Merck
14.3.4 Pfizer
14.3.5 Teva Pharmaceutical
14.3.6 Agile Therapeutics
14.3.7 Amgen
14.3.8 Apothecus Pharmaceutical
14.3.9 AstraZeneca
14.3.10 Blairex Laboratories
14.3.11 Bristol-Myers Squibb
14.3.12 Ferring
